A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

NCT07667803 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

4500

Enrollment

INDUSTRY

Sponsor class

Conditions

Weight Management

Interventions

DRUG: Elecoglipron
DRUG: Placebo

Sponsor

AstraZeneca